Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer

Clinical Trial Site, Hot Springs, Arkansas, United States

Clinical Trial Site, Beverly Hills, California, United States

Clinical Trial Site, La Jolla, California, United States

Clinical Trial Site, Los Alamitos, California, United States

Clinical Trial Site, San Francisco, California, United States

Clinical Trial Site, Santa Barbara, California, United States

Clinical Trial Site, Aurora, Colorado, United States

Clinical Trial Site, Denver, Colorado, United States

Clinical Trial Site, New Haven, Connecticut, United States

Clinical Trial Site, Tampa, Florida, United States

Clinical Trial Site, Marietta, Georgia, United States

Clinical Trial Site, Honolulu, Hawaii, United States

Clinical Trial Site, Peoria, Illinois, United States

Clinical Trial Site, Urbana, Illinois, United States

Clinical Trial Site, Ames, Iowa, United States

Clinical Trial Site, Scarborough, Maine, United States

Clinical Trial Site, Annapolis, Maryland, United States

Clinical Trial Site, Minneapolis, Minnesota, United States

Clinical Trial Site, Jackson, Mississippi, United States

Clinical Trial Site, Kansas City, Missouri, United States

Clinical Trial Site, Santa Fe, New Mexico, United States

Clinical Trial Site, New York, New York, United States

Clinical Trial Site, Charlotte, North Carolina, United States

Clinical Trial Site, Cincinnati, Ohio, United States

Clinical Trial Site, Columbus, Ohio, United States

Clinical Trial Site, Horsham, Pennsylvania, United States

Clinical Trial Site, Sayre, Pennsylvania, United States

Clinical Trial Site, Bartlett, Tennessee, United States

Clinical Trial Site, Knoxville, Tennessee, United States

Clinical Trial Site, Mount Juliet, Tennessee, United States

Clinical Trial Site, Nashville, Tennessee, United States

Clinical Trial Site, Tennessee City, Tennessee, United States

Clinical Trial Site, Denton, Texas, United States

Clinical Trial Site, El Paso, Texas, United States

Clinical Trial Site, Houston, Texas, United States

Clinical Trial Site, San Antonio, Texas, United States

Clinical Trial Site, Salt Lake City, Utah, United States

Clinical Trial Site, Fort Belvoir, Virginia, United States

Clinical Trial Site, Midlothian, Virginia, United States

Clinical Trial Site, Norfolk, Virginia, United States

Clinical Trial Site, Olympia, Washington, United States

Clinical Trial Site, Vancouver, Washington, United States

Clinical Trial Site, Milwaukee, Wisconsin, United States

Clinical Trial Site, Sydney, New South Wales, Australia

Clinical Trial Site, Waratah, New South Wales, Australia

Clinical Trial Site, South Brisbane, Queensland, Australia

Clinical Trial Site, Adelaide, South Australia, Australia

Clinical Trial Site, Clayton, Victoria, Australia

Clinical Trial Site, Geelong, Victoria, Australia

Clinical Trial Site, Heidelberg, Victoria, Australia

Clinical Trial Site, Nedlands, Western Australia, Australia

Clinical Trial Site, Krems, Lower Austria, Austria

Clinical Trial Site, Salzburg, State of Salzburg, Austria

Clinical Trial Site, Linz, Upper Austria, Austria

Clinical Trial Site, Brussels, Brussels Capital, Belgium

Clinical Trial Site, Woluwe-Saint-Lambert, Brussels Capital, Belgium

Clinical Trial Site, Kortrijk, Flanders, Belgium

Clinical Trial Site, Liège, Liège Province, Belgium

Clinical Trial Site, Charleroi, Wallonia, Belgium

Clinical Trial Site, Toronto, Ontario, Canada

Clinical Trial Site, Hořovice, Central Bohemia, Czechia

Clinical Trial Site, Liberec, Liberec Region, Czechia

Clinical Trial Site, Olomouc, Olomouc Region, Czechia

Clinical Trial Site, Prague, Prague, Czechia

Clinical Trial Site, Zlín, Zlín, Czechia

Clinical Trial Site, Pierre-Bénite, Auvergne-Rhône-Alpes, France

Clinical Trial Site, Brest, Brittany Region, France

Clinical Trial Site, Plérin, Brittany Region, France

Clinical Trial Site, Besançon, Doubs, France

Clinical Trial Site, Montpellier, Hérault, France

Clinical Trial Site, Toulouse, Occitanie, France

Clinical Trial Site, Bobigny, France

Clinical Trial Site, Villejuif, Île-de-France Region, France

Clinical Trial Site, Frankfurt, Hassen, Germany

Clinical Trial Site, Düsseldorf, North Rhine-Westphalia, Germany

Clinical Trial Site, Torgau, Saxony, Germany

Clinical Trial Site, Pátrai, Achaia, Greece

Clinical Trial Site, Athens, Attica, Greece

Clinical Trial Site, Athens, Pireas, Greece

Clinical Trial Site, Thessaloniki, Thessaloniki, Greece

Clinical Trial Site, Hong Kong, Hong Kong, Hong Kong

Clinical Trial Site, Hong Kong, Kowloon, Hong Kong

Clinical Trial Site, Hong Kong, Pok Fu Lam, Hong Kong

Clinical Trial Site, Kecskemét, Bács-Kiskun county, Hungary

Clinical Trial Site, Győr, Győr-Moson-Sopron, Hungary

Clinical Trial Site, Debrecen, Hajdú-Bihar, Hungary

Clinical Trial Site, Naples, Campania, Italy

Clinical Trial Site, Bologna, Emilia-Romagna, Italy

Clinical Trial Site, Aviano, Friuli Venezia Giulia, Italy

Clinical Trial Site, Rome, Lazio, Italy

Clinical Trial Site, Genoa, Liguria, Italy

Clinical Trial Site, Bergamo, Lombardy, Italy

Clinical Trial Site, Milan, Lombardy, Italy

Clinical Trial Site, Monza, Lombardy, Italy

Clinical Trial Site, Milan, Milano, Italy

Clinical Trial Site, Prato, Tuscany, Italy

Clinical Trial Site, Milan, Varese, Italy

Clinical Trial Site, Ipoh, Ipoh Perak, Malaysia

Clinical Trial Site, Kuala Lumpur, Kuala Lumpur, Malaysia

Clinical Trial Site, Kuala Lumpur, Kuala Lumpur, Malaysia

Clinical Trial Site, George Town, Pulau Pinang, Malaysia

Clinical Trial Site, Kota Kinabalu, Sabah, Malaysia

Clinical Trial Site, Kuching, Sarawak, Malaysia

Clinical Trial Site, Petaling Jaya, Selangor, Malaysia

Clinical Trial Site, Putrajaya, Wilayah PE, Malaysia

Clinical Trial Site, Apeldoorn, Gelderland, Netherlands

Clinical Trial Site, Maastricht, Limberg, Netherlands

Clinical Trial Site, Amsterdam, North Holland, Netherlands

Clinical Trial Site, Krakow, Lesser Poland Voivodeship, Poland

Clinical Trial Site, Otwock, Mazowieckir, Poland

Clinical Trial Site, Rzeszów, Podkarpackie Voivodeship, Poland

Clinical Trial Site, Rzeszów, Podkarpackie Voivodeship, Poland

Clinical Trial Site, Gdansk, Pomeranian Voivodeship, Poland

Clinical Trial Site, Brzozów, Woj Podkarpackie, Poland

Clinical Trial Site, Lodz, Łódź Voivodeship, Poland

Clinical Trial Site, Lisbon, Lisbon District, Portugal

Clinical Trial Site, Porto, Porto District, Portugal

Clinical Trial Site, Porto, Porto District, Portugal

Clinical Trial Site, Bucharest, Bucharest, Romania

Clinical Trial Site, Cluj-Napoca, Cluj, Romania

Clinical Trial Site, Ovidiu, Constanța County, Romania

Clinical Trial Site, Craiova, Dolj, Romania

Clinical Trial Site, Iași, Iaşi, Romania

Clinical Trial Site, Timișoara, Timiș County, Romania

Clinical Trial Site, Busan, Busan Metropolitan City, South Korea

Clinical Trial Site, Daegu, Daegu Metropolitan City, South Korea

Clinical Trial Site, Goyang-si, Gyeonggi-do, South Korea

Clinical Trial Site, Seongnam-si, Gyeonggi-do, South Korea

Clinical Trial Site, Suwon, Gyeonggi-do, South Korea

Clinical Trial Site, Yongin-si, Gyeonggi-do, South Korea

Clinical Trial Site, Seoul, Seoul, South Korea

Clinical Trial Site 1, Seoul, Seoul, South Korea

Clinical Trial Site 2, Seoul, Seoul, South Korea

Clinical Trial Site, Seoul, Seoul, South Korea

Clinical Trial Site, Seoul, Seoul Special City, South Korea

Clinical Trial Site, Seoul, Seoul Special City, South Korea

Clinical Trial Site, Alicante, Alicante, Spain

Clinical Trial Site, Barcelona, Barcelona, Spain

Clinical Trial Site, Barcelona, Barcelona, Spain

Clinical Trial Site, Barcelona, Barcelona, Spain

Clinical Trial Site, Granada, Granada, Spain

Clinical Trial Site, León, León, Spain

Clinical Trial Site, Lleida, Lleida, Spain

Clinical Trial Site, Madrid, Madrid, Spain

Clinical Trial Site, Madrid, Madrid, Spain

Clinical Trial Site, Madrid, Madrid, Spain

Clinical Trial Site, Madrid, Madrid, Spain

Clinical Trial Site, Murcia, Murcia, Spain

Clinical Trial Site, Seville, Sevilla, Spain

Clinical Trial Site, Valencia, Valencia, Spain

Clinical Trial Site, Zaragoza, Zaragoza, Spain

Clinical Trial Site, Chang-hua, Chang Hua, Taiwan

Clinical Trial Site, Kaohsiung City, Sanmin, Taiwan

Clinical Trial Site, Taipei, Special Municipality, Taiwan

Clinical Trial Site, Taipei, Special Municipality, Taiwan

Clinical Trial Site, Taipei, Taipei City, Taiwan

Clinical Trial Site, Taipei, Taipei City, Taiwan

Clinical Trial Site, Bangkok, Bangkok, Thailand

Clinical Trial Site, Dusit, Bangkok, Thailand

Clinical Trial Site, Ban Phaeo, Changwat Samut Sakhon, Thailand

Clinical Trial Site, Hat Yai, Changwat Songkhla, Thailand

Clinical Trial Site, Chiang Mai, Chiang Mai, Thailand

Clinical Trial Site, Brighton, England, United Kingdom

Clinical Trial Site, London, England, United Kingdom

Clinical Trial Site, London, Greater London, United Kingdom

Clinical Trial Site, Taunton, Somerset, United Kingdom

Clinical Trial Site, Guildford, Surrey, United Kingdom